KD Logo

DarioHealth Corp (DRIO) receives a Buy rating from Alliance Global Partners

DarioHealth Corp’s filing revealed that its Chief Executive Officer Raphael Erez acquired Company’s shares for reported $4400.0 on Aug 27 ’24. In the deal valued at $0.88 per share,5,000 shares were bought. As a result of this transaction, Raphael Erez now holds 1,937,059 shares worth roughly $1.57 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Nelson Steven Charles bought 5,000 shares, generating $4,750 in total proceeds. Upon buying the shares at $0.95, the Chief Commercial Officer now owns 25,000 shares.

Before that, Nelson Steven Charles bought 5,000 shares. DarioHealth Corp shares valued at $4,725 were divested by the Chief Commercial Officer at a price of $0.94 per share. As a result of the transaction, Nelson Steven Charles now holds 20,000 shares, worth roughly $16200.000000000002.

Alliance Global Partners upgraded its DarioHealth Corp [DRIO] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cowen’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. Stifel began covering DRIO with “Buy” recommendation on March 23, 2021. Cantor Fitzgerald started covering the stock on February 25, 2021. It rated DRIO as “an Overweight”.

Price Performance Review of DRIO

On Friday, DarioHealth Corp [NASDAQ:DRIO] saw its stock unchanged to $0.81. Over the last five days, the stock has lost -12.86%. DarioHealth Corp shares have fallen nearly -52.91% since the year began. Nevertheless, the stocks have fallen -74.29% over the past one year. While a 52-week high of $3.49 was reached on 02/15/24, a 52-week low of $0.68 was recorded on 08/09/24. SMA at 50 days reached $1.0759, while 200 days put it at $1.4947.

Levels Of Support And Resistance For DRIO Stock

The 24-hour chart illustrates a support level at 0.7898, which if violated will result in even more drops to 0.7697. On the upside, there is a resistance level at 0.8403. A further resistance level may holdings at 0.8707. The Relative Strength Index (RSI) on the 14-day chart is 35.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0730, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.98%. Stochastics %K at 20.28% indicates the stock is a holding.

How much short interest is there in DarioHealth Corp?

A steep rise in short interest was recorded in DarioHealth Corp stocks on 2024-08-15, growing by 5366.0 shares to a total of 1.62 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-15 was 1.62 million shares. There was a rise of 0.33%, which implies that there is a positive sentiment for the stock.

Most Popular